Subscribe to: Heart Care Info RSS Feed  

Heart Care Info - Heart Disease Prevention & Treatment

  Heart health     Cardiopathy     Heart study     Cardiology      Email A Friend  
Heart disease
Heart attack
Heart failure
Heart surgery
Heart Care Info
Heart transplantation
Bypass surgery
Cardiovascular disease
Arrhythmia
Atherosclerosis
Heart rate
Cardiac arrest
Cardiac death
Cardiac surgery
Cardiovascular system
Cardiomyopathy
Endocarditis
Cardiomegaly
Myocarditis


Monoclonal antibodies targeting IL 1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E deficient mice, atherosclerosis

Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice


Heart Care Guide - http://www.heartcareguide.net

V Bhaskar, J Yin, AM Mirza, D Phan, S Vanegas... - Atherosclerosis, 2011 - Elsevier OBJECTIVE: Atherosclerosis is a condition that is increasingly contributing to worldwide mortality through complications such as stroke and myocardial infarction. IL-1β plays multiple direct, local roles in the formation and stability of the atheroma by eliciting the ...

Atherosclerosis is a condition that is increasingly contributing to worldwide mortality through complications such as stroke and myocardial infarction. IL-1β plays multiple direct, local roles in the formation and stability of the atheroma by eliciting the production of additional cytokines and proteolytic enzymes from macrophages, endothelial cells (EC) and smooth muscle cells (SMC). We therefore tested whether an anti-IL-1β antibody, XOMA 052, might inhibit the secretion of pro-atherogenic cytokines from macrophages in vitro and affect a positive outcome in the Apolipoprotein E-deficient mouse (Apo E / ) model of atherosclerosis in vivo.

In an in vitro co-culture model, XOMA 052 inhibited macrophage-induced secretion of key atherogenic cytokines from EC and SMC, including IL-6, IL-8, MCP-1 and TNFα. The release of degradative enzymes, such as the matrix metalloproteinases MMP-3 and MMP-9, was also decreased by XOMA 052. In addition, XOMA 052 inhibited the secretion of IL-7 from EC and IL-4 from SMC, cytokines not previously reported to be driven by IL-1β in this context. In vivo, XMA052 MG1K, a chimeric murine version of XOMA 052, inhibited the formation of atherosclerotic lesions in the Apo E / model at all three doses tested. This effect was comparable to that reported for complete genetic ablation of IL-1β or IL-1R1 on an Apo E / background and was associated with decreases in plasma non-HDL/HDL cholesterol ratio and plaque lipid content and macrophage infiltration.

More Details:

Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice
Cardiovascular health
Cardiovascular surgery
Coronary artery disease
Coronary artery bypass graft

Subscribe to Heart Care Info by Email
Your email address:

Heart Care Guide
Life & Health Center
Find Doctor in Town
Health Care Jobs
Heart disease treatment